First Manhattan’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-30,000
Closed -$114K 1398
2017
Q1
$114K Hold
30,000
﹤0.01% 783
2016
Q4
$120K Hold
30,000
﹤0.01% 763
2016
Q3
$135K Hold
30,000
﹤0.01% 742
2016
Q2
$147K Hold
30,000
﹤0.01% 734
2016
Q1
$352K Hold
30,000
﹤0.01% 559
2015
Q4
$597K Buy
30,000
+10,000
+50% +$247K ﹤0.01% 485
2015
Q3
$485K Hold
20,000
﹤0.01% 509
2015
Q2
$509K Hold
20,000
﹤0.01% 515
2015
Q1
$481K Hold
20,000
﹤0.01% 522
2014
Q4
$448K Hold
20,000
﹤0.01% 539
2014
Q3
$549K Hold
20,000
﹤0.01% 498
2014
Q2
$636K Buy
20,000
+8,000
+67% +$238K ﹤0.01% 479
2014
Q1
$310K Hold
12,000
﹤0.01% 601
2013
Q4
$312K Buy
12,000
+3,000
+33% +$83.8K ﹤0.01% 594
2013
Q3
$245K Hold
9,000
﹤0.01% 630
2013
Q2
$306K Buy
+9,000
New +$324K ﹤0.01% 589

Other funds holding CLMT

First Manhattan's CLMT Position: Q2 2017 in Review

First Manhattan sold out of Calumet Specialty Products (CLMT) in Q2 2017, closing a stake of 30,000 shares — an estimated $114K sold.

First Manhattan first reported a position in CLMT in Q2 2013 and held it in 16 quarters. The position peaked at $636K in Q2 2014. 72 funds tracked by Wall St. Rank hold CLMT as of Q2 2017.

  • First Manhattan reported no remaining Calumet Specialty Products position as of Q2 2017 after selling out during the quarter.
  • First Manhattan sold 30,000 Calumet Specialty Products shares in Q2 2017, an estimated $114K.
  • First Manhattan first reported a position in Calumet Specialty Products in Q2 2013 and held it in 16 quarters.
  • First Manhattan's Calumet Specialty Products position peaked at $636K in Q2 2014.
  • 72 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2017.

Based on First Manhattan's 13F filing for Q2 2017, filed 28 Jul 2017.